IMMUNEGPT
LIVE

Serial Number

99410386

Owner

Omniscope Limited

Attorney

Carrie A. Johnson

Filing Date

Sep 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNEGPT Trademark

Serial Number: 99410386

IMMUNEGPT is a trademark filed by Omniscope Limited on September 24, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Omniscope Limited (3 trademarks)

230 Works Business Centre, Second Floor
Mosta MST9039 , MT

Entity Type: 78

Trademark Details

Filing Date

September 24, 2025

Registration Date

Not Registered

Goods & Services

Providing medical and clinical analysis services through software for diagnostic and treatment purposes relating to the field of immune cell receptor research

Downloadable and recorded software for the processing and analysis of biological and immune data, using machine learning algorithms trained on biological and immune data, immune cell coutns, T cell receptors (TCRs), B cell receptors (BCRs), Immunosenescence, telomere length, and standard blood biomarkers; Downloadable computer software leveraging artificial intelligence, specifically a transformer-based architecture, for the prediction and generation of immune cell receptor sequences; downloadable computer programs for processing paired and unpaired immune cell receptor data for research and educational purposes; downloadable computer software applications for decoding and synthesizing sequence patterns using proprietary tokenization and context-specific learning algorithms.

Scientific and technical research relating to amino acid sequencing and sequences; Providing online, non-downloadable software for conducting advanced bioinformatics research; Software as a service (SaaS) services featuring cloud-based platforms for modelling, analyzing, and generating immune system receptor sequences using AI-driven methodologies; software as a service (SaaS) and machine learning as a service (MLaaS) featuring software using artificial intelligence for conducting biological sequence analysis tailored to immune cells, T cell receptors (TCRs) and B cell receptors (BCRs); Platform as a service (PAAS) featuring computer software platforms for use in data hosting of immune cell sequencing datasets for educational and professional research; developing specialized software frameworks for others that employ causal masking and custom loss functions for immune receptor study; scientific consultation services relating to the use of AI in immunology and molecular biology research; providing online non-downloadable AI-powered software for the evaluation and interpretation of T cell receptor (TCR) and B cell receptor (BCR) sequences to support medical diagnostics and immunological studies; medical research services for the purpose of enabling advanced predictive modelling for immune system behavior; computer software consulting services relating to clinical software applications involving bioinformatics and immune cell sequencing data; development of computer software for others for the purpose of supporting healthcare and therapeutic research by offering tools for understanding immune interactions through data-driven analysis software

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 24, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 24, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jul 24, 2026 CNSL
ASSIGNED TO EXAMINER
Jul 22, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 15, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 15, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 20, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 18, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 24, 2025 MAFR
NEW APPLICATION ENTERED
Sep 24, 2025 NWAP